Release Date: 17/02/12 14:27 Summary: Amended Change of Substantial Holder Price Sensitive: No Download Document 1.57MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%